Structure-based drug discovery using proprietary DragonFold 3D deep-learning to predict protein-ligand co-folding for hard targets, initially in oncology.
Locations
London, United Kingdom (Headquarters)
The Stanley Building, 7 Pancras Square, London, Greater London, N1C 4AG, United Kingdom